A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter?

Stefano MarventanoDepartment of Medical, Surgical Sciences, and Advanced Technologies “G.F. Ingrassia”, Section of Hygiene and Public Health, University of Catania, Catania, Italy,

Paulina KolaczDepartment of Human Nutrition, Jagiellonian University Medical College in Krakow, Krakow, Poland,

Sabrina CastellanoDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy, and

Fabio GalvanoDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy, and

Silvio BuscemiDepartment of Internal Medicine, University of Palermo, Palermo, Italy

Antonio MistrettaDepartment of Medical, Surgical Sciences, and Advanced Technologies “G.F. Ingrassia”, Section of Hygiene and Public Health, University of Catania, Catania, Italy,

Giuseppe GrossoDepartment of Medical, Surgical Sciences, and Advanced Technologies “G.F. Ingrassia”, Section of Hygiene and Public Health, University of Catania, Catania, Italy, Correspondence[email protected]

show all

A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter?

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter?

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date